English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  T1ρ‐based dynamic glucose‐enhanced (DGEρ) MRI at 3 T: method development and early clinical experience in the human brain

Herz, K., Lindig, T., Deshmane, A., Schittenhelm, J., Skardelly, M., Bender, B., et al. (2019). T1ρ‐based dynamic glucose‐enhanced (DGEρ) MRI at 3 T: method development and early clinical experience in the human brain. Magnetic Resonance in Medicine, 82(5), 1832-1847. doi:10.1002/mrm.27857.

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/21.11116/0000-0003-DDD0-9 Version Permalink: http://hdl.handle.net/21.11116/0000-0004-6E15-A
Genre: Journal Article

Files

show Files

Locators

show
hide
Description:
-

Creators

show
hide
 Creators:
Herz, K1, 2, Author              
Lindig, T1, 2, Author              
Deshmane, A1, 2, Author              
Schittenhelm, J, Author
Skardelly, M, Author
Bender, B, Author              
Ernemann, U, Author
Scheffler, K1, 2, Author              
Zaiss, M1, 2, Author              
Affiliations:
1Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society, ou_1497796              
2Max Planck Institute for Biological Cybernetics, Max Planck Society, ou_1497794              

Content

show
hide
Free keywords: -
 Abstract: Purpose: The aim of this study was to translate the T1ρ‐based dynamic glucose‐enhanced (DGEρ) experiment from ultrahigh magnetic field strengths to a clinical field strength of 3 T. Although the protocol would seem to be as simple as gadolinium‐enhanced imaging, several obstacles had to be addressed, including signal‐to‐noise ratio (SNR), robustness of contrast, and postprocessing, especially motion correction. Methods Spin‐lock based presaturation and a 3D gradient‐echo snapshot readout were optimized for 3 T with regard to robustness, chemical exchange saturation transfer effect strength, and SNR. Postprocessing steps, including dynamic B0 and motion correction, were analyzed and optimized in 7 healthy volunteers. The final protocol, including glucose injection, was applied to 3 glioblastoma patients. Results With appropriate postprocessing, motion‐related artifacts could be drastically reduced, and an SNR of approximately 90 could be achieved for a single dynamic measurement. In 2 patients with blood–brain barrier breakdown, a significant glucose uptake could be observed with a DGEρ effect strength in the range of 0.4% of the water signal. Thorough analysis of possible residual motion revealed that the statistical evidence can decrease when tested against pseudo effects attributed to uncorrected motion. Conclusion DGEρ imaging was optimized for clinical field strengths of 3 T, and a robust protocol was established for broader application. Early experience shows that DGEρ seems possible at 3 T and could not only be attributed to motion artifacts. Observed DGEρ maps showed unique patterns, partly matching with the T1‐ce tumor ring enhancement. However, effect sizes are small and careful clinical application is necessary.

Details

show
hide
Language(s):
 Dates: 2019-062019-11
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Method: -
 Identifiers: DOI: 10.1002/mrm.27857
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Magnetic Resonance in Medicine
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: New York : Wiley-Liss
Pages: - Volume / Issue: 82 (5) Sequence Number: - Start / End Page: 1832 - 1847 Identifier: ISSN: 0740-3194
CoNE: https://pure.mpg.de/cone/journals/resource/954925538149